NASDAQ
Candel Therapeutics, Inc. (CADL) has a fcf yield of -13.00% as of Friday, May 29, 2026. This represents a 68.59% increase compared to its 12-month average of -41.39%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.